Fri Jan 24 10:00:00 UTC 2025: ## Laurus Labs Stock Up Despite USFDA Observation; Indian Options Trading Summit Announced

**Mumbai, January 23, 2025** – Laurus Labs share price opened 1% higher today, trading at Rs 579.00, despite a recent US Food and Drug Administration (USFDA) inspection of its US subsidiary, Laurus Generics Inc. (LGI). The inspection, conducted between January 13th and 21st, resulted in a Form 483 with one observation regarding adverse drug experience reporting practices. The company stated it will address the observation within the stipulated timeframe.

Meanwhile, Traders Gurukul announced its India’s Largest Regional Retail Option Traders Summit (BOTS), a monthly event held on the second or third Sunday of each month across major Indian cities. The summit aims to provide an accessible platform for options traders and generate leads for brokers.

Laurus Labs’ board will meet on Friday, January 24th, to approve the unaudited financial results for the quarter and nine months ending December 31st, 2024. For continued market updates, including Budget 2025 news and Sensex/Nifty movements, visit Moneycontrol or download the Moneycontrol app.

Read More